|
Market Cap (5-Jun) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
PAA released this announcement to the ASX on 9 July 2021, 8:19. The announcement is not marked as price sensitive, and is 33 page(s) in length and 5.84MB in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Science Week Conference Presentation | 9 July 2021, 8:19 |
| PharmAust establishes monepantel GMP tablet stability | 7 July 2021, 8:22 |
| Phase IIb Dog Trial Achieves Interim Clinical Endpoints | 28 June 2021, 8:29 |
| PharmAust receives ethics approval for Phase I trial in MND | 2 June 2021, 8:23 |
You must be logged in to post a reply.
PharmAust 